PNC Financial Services Group’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
VCM
PCM
GAM
LP
PNC Financial Services Group's PLSE Position: Q1 2026 in Review
PNC Financial Services Group increased its Pulse Biosciences (PLSE) stake by 0.23% in Q1 2026, buying an estimated $240 and bringing the position to 5,585 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #2685.
PNC Financial Services Group first reported a position in PLSE in Q1 2017 and has held it in 27 quarters since. The position peaked at $242K in Q4 2023. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.
- PNC Financial Services Group held 5,585 shares of Pulse Biosciences worth $121K as of Q1 2026.
- PNC Financial Services Group bought 13 Pulse Biosciences shares in Q1 2026, an estimated $240.
- Pulse Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2685 holding.
- PNC Financial Services Group first reported a position in Pulse Biosciences in Q1 2017 and has held it in 27 quarters since.
- PNC Financial Services Group's Pulse Biosciences position peaked at $242K in Q4 2023.
- 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.